Glenmark Generics Inc., USA, the subsidiary of Glenmark Generics (GGL), has been granted final approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Fluocinonide Cream USP 0.1%, the ... Indian-Commodity, 1 month ago
Glenmark gets final nod from USFDA for skin cream - Press Trust of India, 1 month ago
Glenmark Generics receives final ANDA approval for Fluocinonide cream - Moneycontrol.com, 1 month ago
Case Name: Sanofi-Aventis Deutschland GmBH v. Glenmark Pharms Inc. , 748 F.3d 1354 (Fed. Cir. Apr. 21, 2014) (Circuit Judges Newman, Linn and Wallach presiding; Opinion by Newman) (Appeal from D.N.J., Cavanaugh, J.) Drug Product and ...JD Supra, 4 weeks ago GLENMARK PHARMACEUTICALS : Gets nod for skin infection cream 4 Traders, 1 month ago GLENMARK GETS NOD FOR SKIN INFECTION CREAM Pharmacy Choice, 1 month ago
The facility will be situated in Monroe, North Carolina, USA The facility will manufacture oral solids, injectables and topicals over a five year period Mumbai, India; July 17, 2014: Glenmark Pharmaceuticals Ltd; a research-driven, global, ...FiercePharmaManufacturing, 3 weeks ago Glenmark to set up production unit in U.S. The Hindu, 1 month ago Glenmark plans to set up new facility in US Hindu Business Line, 1 month ago Glenmark to set up first manufacturing facility in US Business Standard India, 1 month ago
/PRNewswire/ -- Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights -- India Business grew by 20.87% to Rs. 3,971.59 Mn -- US Business grew by 9.33% to Rs. 4,886.70 Mn -- Rest of World (ROW) Business grew by ...Scottrade, 1 month ago Glenmark net profit surges by 43.7% in Q1 PharmaBiz, 1 month ago
Glenmark Pharma soars on entering Oncology with discovery of IND enabling studies of innovative b...
Glenmark Pharmaceuticals is currently trading at Rs. 736.50, up by 17.05 points or 2.37% from its previous closing of Rs. 719.45 on the BSE. The scrip opened at Rs. 726.00 and has touched a high and low of Rs. 749.05 and Rs. 726.00 respectively.Arihant Capital, 1 week ago Glenmark Pharma enters Oncology with discovery of IND enabling studies of innovative bispecific antibody Indian-Commodity, 1 week ago
Glenmark Pharmaceuticals is currently trading at Rs. 565.95, up by 1.40 points or 0.25% from its previous closing of Rs. 564.55 on the BSE. The scrip opened at Rs. 564.60 and has touched a high and low of Rs. 568.00 and Rs. 558.50 respectively. So ...Arihant Capital, 1 month ago Glenmark Pharma surges on plan to set up new manufacturing facility in US Arihant Capital, 1 month ago
Glenmark Pharmaceuticals is currently trading at Rs 546.25, up by 7.10 points or 1.32% from its previous closing of Rs. 539.15 on the BSE. The scrip opened at Rs 542.00 and has touched a high and low of Rs 557.00 and Rs. 542.00 respectively. So ...Arihant Capital, 1 month ago Glenmark Pharmaceuticals gains as its arm receives final ANDA approval for Telmisartan Tablets Arihant Capital, 1 month ago
About Court Report: Each week we will report briefly on recently filed biotech and pharma cases . Cephalon Inc. v. Actavis Laboratories FL Inc. et al. 1:14-cv-00776; filed June 19, 2014 in the District Court of Delaware • Plaintiff: ...JD Supra, 2 months ago Court Report - July 2014 #3 JD Supra, 4 weeks ago
provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential ...MarketResearch.com, 1 month ago
Key benchmark indices dropped as caution prevailed ahead of the release of minutes from the US Federal Reserve's latest meeting. The barometer index, the S&P BSE Sensex, hit its lowest closing level in almost a week. The Sensex shed 106.38 points or ...Business Standard India, 6 days ago
on your WebpageAdd Widget >Get your members hooked!